Skyways Air IPO opens for subscription on March 18, 2026, and closes on March 20, 2026, with an issue size of approximately ₹347.82 crore consisting of a fresh issue of 2.89 crore equity shares and an offer for sale of 1.33 crore shares for listing on BSE and NSE mainboard on March 25. Mumbai-based Skyways Air Services operates as India’s leading air freight forwarder handling temperature-sensitive cargo including pharmaceuticals through multi-modal logistics solutions. Skyways Air IPO proceeds fund ₹216.79 crore debt repayment and ₹130 crore working capital enhancement supporting expansion with international airline partnerships like Air India Cargo and Lufthansa.
₹00
₹
₹
Expert Opinions
Market sentiment for Skyways Air IPO favors logistics investors tracking aviation recovery, supported by FY25 revenue doubling to ₹2,271 crore despite modest margins flagged in analyst previews. Company strengths include temperature-controlled pharma cargo expertise, partnerships with Air India Cargo Lufthansa, multi-modal network spanning 50+ airports, 72% revenue growth trajectory, and established cold chain infrastructure.
Risks and challenges encompass thin 2.14% PAT margins vulnerable to fuel volatility, customer concentration exceeding 60% from top clients, working capital cycles stretching receivables, regulatory changes in air freight, and competition from DHL FedEx. Valuation analysis of Skyways Air IPO and year 2025 reveals Return on Equity (ROE) of 19.52%, ROCE of 14.61%, and Net Asset Value (NAV) of ₹23.40, trading at reasonable multiples for scale-up logistics. Long-term investment perspective benefits from 15% air cargo CAGR driven by e-pharma exports and UDAN connectivity expansion.
Investor Considerations
Skyways Air IPO reflects resilient company performance and fundamentals in FY25, with revenue climbing to ₹2,248 crore through diversified air freight operations and temperature-controlled pharma logistics expertise. Air cargo logistics sector outlook accelerates at 15% CAGR propelled by e-commerce penetration and UDAN regional connectivity expansion. IPO Valuation of Financial Year 2025 for Skyways Air IPO and year shows RONW of 15.85%, PAT Margin of 2.68%, and EBITDA Margin of 3.75%, reflecting operational efficiency amid scale-up pressures.
Growth prospects harness ₹216 crore debt reduction enhancing margins, international airline partnerships expansion, and cold chain infrastructure investments targeting pharma exports. Risk factors include customer concentration exceeding 60%, working capital strains from receivables cycles, fuel price volatility, regulatory shifts in aviation freight, and competition from global integrators. Short-term investment goals capture aviation recovery listing momentum, while long-term horizons benefit from sustained e-pharma logistics compounding.
| Date | GMP | Trend |
|---|---|---|
| 10 Mar 2026 21.24 | ₹00 | --- |
| 08 Mar 2026 17.51 | ₹00 | --- |
FAQs
Skyways Air IPO Current GMP is ₹00.
Skyways Air IPO Expected Returns is 0.00%.
Skyways Air IPO estimated listing price is ₹00.